Cures Within Reach’s mission is to leverage the speed, safety and cost-effectiveness of repurposing, testing already approved therapies for new diseases: driving more treatments to more patients more quickly.
Our focus: providing seed funds for proof-of-concept or pivotal studies that, when successful, allow a catalytic effect of follow-on funding for trials that build clinical evidence for regulatory approval or for off-label use.
Our 2023 Annual Report is available here.
Read about our newest success story in tuberculosis and our new organizational records achieved during 2023:
- $16 million in follow-on funding raised by our researchers
- 16 clinical trials started
- 10 clinical trials completed
Read our January 2024 news release announcing our newest success story in tuberculosis, our new funding partner for LMICs and the 4 LMIC-based clinical trials selected in 2023.
Learn about our 2024 initiatives:
in Pediatrics
for Veterans/Military
and for Underrepresented Patients and Researchers.
Diseases Researched
Repurposing Trials Funded
Institutions Funded
Success Stories
Startups with CWR Investments
Companies Commercializing CWR Projects
Millions of Dollars in Project Funding
